Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases

BACKGROUND AIMS: Cord blood (CB) transplantation slows neurodegeneration during certain inherited metabolic diseases. However, the number of donor cells in the brain of patients does not appear to be sufficient to provide benefit until several months after transplant. We developed the cell product D...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cytotherapy
Autori principali: KURTZBERG, JOANNE, BUNTZ, SUSAN, GENTRY, TRACY, NOELDNER, PAMELA, OZAMIZ, APRIL, RUSCHE, BENJAMIN, STORMS, ROBERT W., WOLLISH, AMY, WENGER, DAVID A., BALBER, ANDREW E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843803/
https://ncbi.nlm.nih.gov/pubmed/25770677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2015.02.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi